Literature DB >> 10712435

Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex.

J Kero1, M Poutanen, F P Zhang, N Rahman, A M McNicol, J H Nilson, R A Keri, I T Huhtaniemi.   

Abstract

Transgenic (TG) female mice expressing bLHbeta-CTP (a chimeric protein derived from the beta-subunit of bovine luteinizing hormone [LH] and a fragment of the beta-subunit of human chorionic gonadotropin [hCG]) exhibit elevated serum LH, infertility, polycystic ovaries, and ovarian tumors. In humans, increased LH secretion also occurs in infertility and polycystic ovarian syndrome, often concomitant with adrenocortical dysfunction. We therefore investigated adrenal function in LH overexpressing bLHbeta-CTP female mice. The size of their adrenals was increased by 80% with histological signs of cortical stimulation. Furthermore, adrenal steroid production was increased, with up to 14-fold elevated serum corticosterone. Primary adrenal cells from TG and control females responded similarly to ACTH stimulation, but, surprisingly, the TG adrenals responded to hCG with significantly increased cAMP, progesterone, and corticosterone production. LH receptor (LHR) expression and activity were also elevated in adrenals from female TG mice, but gonadectomized TG females showed no increase in corticosterone, suggesting that the dysfunctional ovaries of the intact TG females promote adrenocortical hyperfunction. We suggest that, in intact TG females, enhanced ovarian estrogen synthesis causes increased secretion of prolactin (PRL), which elevates LHR expression. Chronically elevated serum LH, augmented by enhanced PRL production, induces functional LHR expression in mouse adrenal cortex, leading to elevated, LH-dependent, corticosterone production. Thus, besides polycystic ovaries, the bLHbeta-CTP mice provide a useful model for studying human disorders related to elevated LH secretion and adrenocortical hyperfunction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712435      PMCID: PMC289173          DOI: 10.1172/JCI7716

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Leuprolide acetate therapy in luteinizing hormone--dependent Cushing's syndrome.

Authors:  A Lacroix; P Hamet; J M Boutin
Journal:  N Engl J Med       Date:  1999-11-18       Impact factor: 91.245

2.  An enzymatic solid-phase method for trace iodination of proteins and peptides with 125-iodine.

Authors:  S L Karonen; P Mörsky; M Siren; U Seuderling
Journal:  Anal Biochem       Date:  1975-07       Impact factor: 3.365

3.  Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH.

Authors:  J R Givens; R N Andersen; J B Ragland; W L Wiser; E S Umstot
Journal:  J Clin Endocrinol Metab       Date:  1975-06       Impact factor: 5.958

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  X-zone degeneration in the adrenal glands of adult and immature female mice.

Authors:  P V Holmes; A D Dickson
Journal:  J Anat       Date:  1971-01       Impact factor: 2.610

6.  [Effect of testosterone and progesterone on the adrenal X-zone in female mice (author's transl)].

Authors:  M Asari; K Fukaya; Y Eguchi; S Nishida; Y Kano
Journal:  Nihon Juigaku Zasshi       Date:  1979-02

7.  Corticosterone concentrations in the mouse.

Authors:  D H Spackman; V Riley
Journal:  Science       Date:  1978-04-07       Impact factor: 47.728

8.  Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.

Authors:  J F Harper; G Brooker
Journal:  J Cyclic Nucleotide Res       Date:  1975

9.  Chronic hypersecretion of luteinizing hormone in transgenic mice selectively alters responsiveness of the alpha-subunit gene to gonadotropin-releasing hormone and estrogens.

Authors:  R A Abbud; R K Ameduri; J S Rao; T M Nett; J H Nilson
Journal:  Mol Endocrinol       Date:  1999-09

10.  Adrenocortical function in puberty. serum ACTH, cortisol and dehydroepiandrosterone in girls and boys.

Authors:  D Apter; A Pakarinen; G L Hammond; R Vihko
Journal:  Acta Paediatr Scand       Date:  1979-07
View more
  35 in total

Review 1.  The ovarian gonadotropin receptors in health and disease.

Authors:  Paul A Fowler; Ilpo T Huhtaniemi
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

2.  Female mice expressing constitutively active mutants of FSH receptor present with a phenotype of premature follicle depletion and estrogen excess.

Authors:  Hellevi Peltoketo; Leena Strauss; Riikka Karjalainen; Meilin Zhang; Gordon W Stamp; Deborah L Segaloff; Matti Poutanen; Ilpo T Huhtaniemi
Journal:  Endocrinology       Date:  2010-02-19       Impact factor: 4.736

3.  Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.

Authors:  M D Landis; D D Seachrist; F W Abdul-Karim; R A Keri
Journal:  Oncogene       Date:  2006-01-23       Impact factor: 9.867

Review 4.  The transient cortical zone in the adrenal gland: the mystery of the adrenal X-zone.

Authors:  Chen-Che Huang; Yuan Kang
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

Review 5.  Aberrant expression of hormone receptors in adrenal Cushing's syndrome.

Authors:  Stavroula Christopoulos; Isabelle Bourdeau; André Lacroix
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

6.  Testosterone-secreting gonadotropin-responsive adrenal adenoma and its treatment with the antiandrogen flutamide.

Authors:  F A Lószió; S Tóth; J Kocsis; M Szécsi
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

7.  Bone phenotypes in response to gonadotropin misexpression: the role for gonadotropins in postmenopausal osteoporosis.

Authors:  Jason P Mansell
Journal:  Int J Gen Med       Date:  2008-11-30

8.  Transgenic GATA-4 expression induces adrenocortical tumorigenesis in C57Bl/6 mice.

Authors:  Marcin Chrusciel; Susanna Vuorenoja; Bidut Mohanty; Adolfo Rivero-Müller; Xiangdong Li; Jorma Toppari; Ilpo Huhtaniemi; Nafis A Rahman
Journal:  J Cell Sci       Date:  2013-02-26       Impact factor: 5.285

9.  Case report: Adrenal LH/hCG receptor overexpression and gene amplification causing pregnancy-induced Cushing's syndrome.

Authors:  Michael Herman Chui; Michael Herman Chui; Nese Colak Ozbey; Shereen Ezzat; Yersu Kapran; Yesim Erbil; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

10.  Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer.

Authors:  E L Milliken; K L Lozada; E Johnson; M D Landis; D D Seachrist; I Whitten; A L M Sutton; F W Abdul-Karim; R A Keri
Journal:  Oncogene       Date:  2007-09-24       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.